✦ LIBER ✦

1FC2.3 The Identification of a Viable Outcome Measure in the Collagen VI Myopathies Promotes Progress Toward Clinical Trials

✍ Scribed by A. Reghan Foley; S. Quijano-Roy; J. Collins; V. Straub; N. Deconinck; E.M. Mercuri; A. D'Amico; E. Bertini; K. North; M. Ryan; F. Muntoni; C. Bönnemann

Book ID: 114360292
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 15
Category: Article
ISSN: 1090-3798
DOI: 10.1016/s1090-3798(11)70049-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2.5 The identification of a viable outc

P2.5 The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials

✍ A.R. Foley; S. Quijano-Roy; J. Collins; V. Straub; N. Deconinck; E. Mercuri; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P62 The identification of a viable outco

P62 The identification of a viable outcome measure in the collagen VI myopathies promotes progress toward clinical trials

✍ A.R. Foley; S. Qmijano-Roy; J. Collins; V. Straub; N. Deconinck; E. Mercuri; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Critical evaluation of the use of cell c

Critical evaluation of the use of cell cultures for inclusion in clinical trials of patients affected by collagen VI myopathies

✍ P. Sabatelli; E. Palma; A. Angelin; S. Squarzoni; A. Urciuolo; C. Pellegrini; T. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB